tv3326 has been researched along with 6-chlorotacrine in 2 studies
Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (6-chlorotacrine) | Trials (6-chlorotacrine) | Recent Studies (post-2010) (6-chlorotacrine) |
---|---|---|---|---|---|
15 | 0 | 11 | 28 | 0 | 20 |
Protein | Taxonomy | tv3326 (IC50) | 6-chlorotacrine (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.051 | |
Cholinesterase | Homo sapiens (human) | 0.8458 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 6.09 | |
Acetylcholinesterase | Mus musculus (house mouse) | 0.0198 | |
Acetylcholinesterase | Homo sapiens (human) | 0.0535 | |
Acetylcholinesterase | Bos taurus (cattle) | 0.31 | |
Cholinesterase | Equus caballus (horse) | 0.0165 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kumar, A; Mishra, P; Panda, G | 1 |
do Carmo Carreiras, M; Ismaili, L; Marco-Contelles, J | 1 |
2 review(s) available for tv3326 and 6-chlorotacrine
Article | Year |
---|---|
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents | 2019 |
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Cholinesterases; Humans; Ligands; Monoamine Oxidase; Neuroprotective Agents; Oxidative Stress; Pargyline; Propylamines | 2020 |